Ausgabe 4/2009
Inhalt (24 Artikel)
Prediction of type 2 diabetes: the dawn of polygenetic testing for complex disease
J. B. Meigs
Adipose tissue–skeletal muscle crosstalk: are endocannabinoids an unwanted caller?
M. J. Watt
Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants
M. A. Abdul-Ghani, R. Jani, A. Chavez, M. Molina-Carrion, D. Tripathy, R. A. DeFronzo
Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trøndelag Health Study (HUNT)
B. Hildrum, A. Mykletun, A. A. Dahl, K. Midthjell
Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study
J. Poehls, C. L. Wassel, T. B. Harris, P. J. Havel, M. M. Swarbrick, S. R. Cummings, A. B. Newman, S. Satterfield, A. M. Kanaya
Cardiovascular risk factors in the normoglycaemic Asian-Indian population—influence of urbanisation
C. Snehalatha, A. Ramachandran
Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score—the CoLaus Study
X. Lin, K. Song, N. Lim, X. Yuan, T. Johnson, A. Abderrahmani, P. Vollenweider, H. Stirnadel, S. S. Sundseth, E. Lai, D. K. Burns, L. T. Middleton, A. D. Roses, P. M. Matthews, G. Waeber, L. Cardon, D. M. Waterworth, V. Mooser
PPARGC1A sequence variation and cardiovascular risk-factor levels: a study of the main genetic effects and gene × environment interactions in children from the European Youth Heart Study
E. C. Brito, K. S. Vimaleswaran, S. Brage, L. B. Andersen, L. B. Sardinha, N. J. Wareham, U. Ekelund, R. J. F. Loos, P. W. Franks
TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study
E. S. Stolerman, A. K. Manning, J. B. McAteer, C. S. Fox, J. Dupuis, J. B. Meigs, J. C. Florez
A simple two-step protocol for the purification of human pancreatic beta cells
M. Banerjee, T. Otonkoski
Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis
S. Zraika, R. L. Hull, J. Udayasankar, K. Aston-Mourney, S. L. Subramanian, R. Kisilevsky, W. A. Szarek, S. E. Kahn
Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets
M. Shaked, M. Ketzinel-Gilad, Y. Ariav, E. Cerasi, N. Kaiser, G. Leibowitz
Differentiation of COPAS-sorted non-endocrine pancreatic cells into insulin-positive cells in the mouse
R. Kikugawa, H. Katsuta, T. Akashi, S. Yatoh, G. C. Weir, A. Sharma, S. Bonner-Weir
Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice
M. Akiyama, M. Hatanaka, Y. Ohta, K. Ueda, A. Yanai, Y. Uehara, K. Tanabe, M. Tsuru, M. Miyazaki, S. Saeki, T. Saito, K. Shinoda, Y. Oka, Y. Tanizawa
Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle
K. Eckardt, H. Sell, A. Taube, M. Koenen, B. Platzbecker, A. Cramer, A. Horrighs, M. Lehtonen, N. Tennagels, J. Eckel
Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet
T. Kusakabe, H. Tanioka, K. Ebihara, M. Hirata, L. Miyamoto, F. Miyanaga, H. Hige, D. Aotani, T. Fujisawa, H. Masuzaki, K. Hosoda, K. Nakao
Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations
A. Kotronen, V. R. Velagapudi, L. Yetukuri, J. Westerbacka, R. Bergholm, K. Ekroos, J. Makkonen, M.-R. Taskinen, M. Orešič, H. Yki-Järvinen
Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis
G. M. Magee, R. W. Bilous, C. R. Cardwell, S. J. Hunter, F. Kee, D. G. Fogarty
Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients
S. T. Knudsen, E. Laugesen, K. W. Hansen, T. Bek, C. E. Mogensen, P. L. Poulsen
Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study
J. W. M. Nin, I. Ferreira, C. G. Schalkwijk, M. H. Prins, N. Chaturvedi, J. H. Fuller, C. D. A. Stehouwer
A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study
G. J. S. Cooper, A. A. Young, G. D. Gamble, C. J. Occleshaw, A. M. Dissanayake, B. R. Cowan, D. H. Brunton, J. R. Baker, A. R. J. Phillips, C. M. Frampton, S. D. Poppitt, R. N. Doughty
Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial
D. K. Coletta, A. Sriwijitkamol, E. Wajcberg, P. Tantiwong, M. Li, M. Prentki, M. Madiraju, C. P. Jenkinson, E. Cersosimo, N. Musi, R. A. DeFronzo
A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population
C. Hu, R. Zhang, C. Wang, X. Ma, C. Wang, Q. Fang, Y. Bao, K. Xiang, W. Jia